Vanguard Group’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$859K Sell
767,154
-108,415
-12% -$121K ﹤0.01% 3779
2025
Q1
$1.01M Sell
875,569
-20,781
-2% -$23.9K ﹤0.01% 3708
2024
Q4
$5.48M Buy
896,350
+6,150
+0.7% +$37.6K ﹤0.01% 3232
2024
Q3
$14.7M Buy
890,200
+11,579
+1% +$192K ﹤0.01% 2756
2024
Q2
$6.04M Buy
878,621
+24,963
+3% +$171K ﹤0.01% 3173
2024
Q1
$8.24M Sell
853,658
-43,491
-5% -$420K ﹤0.01% 3066
2023
Q4
$7.46M Sell
897,149
-2,858
-0.3% -$23.8K ﹤0.01% 3115
2023
Q3
$7.52M Buy
900,007
+202,719
+29% +$1.69M ﹤0.01% 3059
2023
Q2
$6.44M Buy
697,288
+116,926
+20% +$1.08M ﹤0.01% 3184
2023
Q1
$7.97M Buy
580,362
+3,195
+0.6% +$43.9K ﹤0.01% 3066
2022
Q4
$9.82M Buy
577,167
+57,190
+11% +$973K ﹤0.01% 2956
2022
Q3
$11.8M Buy
519,977
+9,044
+2% +$206K ﹤0.01% 2870
2022
Q2
$9.21M Sell
510,933
-319,144
-38% -$5.75M ﹤0.01% 3041
2022
Q1
$22.2M Buy
830,077
+415,028
+100% +$11.1M ﹤0.01% 2707
2021
Q4
$12.2M Buy
415,049
+2,490
+0.6% +$73K ﹤0.01% 3114
2021
Q3
$27.1M Buy
412,559
+2,756
+0.7% +$181K ﹤0.01% 2680
2021
Q2
$34.1M Buy
409,803
+5,702
+1% +$474K ﹤0.01% 2570
2021
Q1
$31M Sell
404,101
-36,830
-8% -$2.82M ﹤0.01% 2572
2020
Q4
$38.9M Buy
440,931
+69,077
+19% +$6.1M ﹤0.01% 2326
2020
Q3
$27.4M Sell
371,854
-100,018
-21% -$7.38M ﹤0.01% 2305
2020
Q2
$34.4M Sell
471,872
-28,007
-6% -$2.04M ﹤0.01% 2185
2020
Q1
$28.1M Sell
499,879
-4,802
-1% -$270K ﹤0.01% 2133
2019
Q4
$19.3M Buy
504,681
+479,681
+1,919% +$18.3M ﹤0.01% 2551
2019
Q3
$443K Buy
+25,000
New +$443K ﹤0.01% 3840